ab Global Equity Research Americas UBS Investment Research Banks, Ex-S&L Canadian Banks: Q4/F10 Snapshot Sector Comment Higher expenses, slower projected growth, PCLs stabilizing; but trading rebounded 6 December 2010 www.ubs.com/investmentresearch NA, CM, and BNS beat consensus EPS expectations; RY and TD did not NA and CM outperformed due to good growth in Canadian Banking. EPS guidance was unchanged, but some ROE’s were capped (Q4 ROEs were 15.3%). Peter A. Rozenberg NA raised dividends, as expected. BNS increased its target payout signalling an Analyst increase. All banks noted Basel III compliance. RY and TD results were email@example.com disappointing due to expenses; BNS was in line: acquisitions provided a boost. +1-416-350 2801 Expenses were much higher than expected, but should normalize over time Higher expenses were largely due to marketing and other initiatives. NIX was up 2.3% q/q. While some of this was one-time, it underlined increasing competition and slower growth. We continue to think expenses could be a key differentiator. Canadian P&C up 17% y/y, but down 5% q/q; trading strongly rebounded Loan growth was 5% y/y, but moderating; with business lending rebounding. Margins increased 3 bps due to higher rates, but are expected to flatten. Credit improved, down 2 bps q/q, but is now stabilizing. Market Sensitive revenues strongly rebounded, up 28% q/q, largely due to trading. (Refer to Table 1). Organic and Int’l growth, higher ROE’s, and capital deployment key Buy rated BNS, CM, have significantly outperformed YTD. However, Buy rated RY has not likely due to capital markets and expenses. Nonetheless, we think RY remains amongst the best positioned banks to achieve above average EPS growth, cost reduction, capital markets growth and deploy capital. This report has been prepared by UBS Securities Canada Inc ANALYST CERTIFICATION AND REQUIRED DISCLOSURES BEGIN ON PAGE 3. UBS does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.
Canadian Banks: Q4/F10 Snapshot 6 December 2010 Statement of RiskRisks include the general economic outlook including loan growth,unemployment, the level of interest rates, inflation, consumer indebtedness,corporate profits, loan losses, competition, foreign exchange, impact ofacquisitions, securities and trading losses, capital market activity, taxes, as wellapolitical and regulatory risk. Analyst CertificationEach research analyst primarily responsible for the content of this researchreport, in whole or in part, certifies that with respect to each security or issuerthat the analyst covered in this report: (1) all of the views expressed accuratelyreflect his or her personal views about those securities or issuers; and (2) no partof his or her compensation was, is, or will be, directly or indirectly, related tothe specific recommendations or views expressed by that research analyst in theresearch report. UBS 3
Canadian Banks: Q4/F10 Snapshot 6 December 2010Required DisclosuresThis report has been prepared by UBS Securities Canada Inc, an affiliate of UBS AG. UBS AG, its subsidiaries,branches and affiliates are referred to herein as UBS.For information on the ways in which UBS manages conflicts and maintains independence of its research product;historical performance information; and certain additional disclosures concerning UBS research recommendations,please visit www.ubs.com/disclosures. The figures contained in performance charts refer to the past; past performance isnot a reliable indicator of future results. Additional information will be made available upon request.UBS Securities Co. Limited is licensed to conduct securities investment consultancy businesses by the China SecuritiesRegulatory Commission.UBS Investment Research: Global Equity Rating Allocations 1 2 UBS 12-Month Rating Rating Category Coverage IB Services Buy Buy 51% 37% Neutral Hold/Neutral 40% 33% Sell Sell 9% 22% 3 4 UBS Short-Term Rating Rating Category Coverage IB Services Buy Buy less than 1% 20% Sell Sell less than 1% 0%1:Percentage of companies under coverage globally within the 12-month rating category.2:Percentage of companies within the 12-month rating category for which investment banking (IB) services were provided withinthe past 12 months.3:Percentage of companies under coverage globally within the Short-Term rating category.4:Percentage of companies within the Short-Term rating category for which investment banking (IB) services were providedwithin the past 12 months.Source: UBS. Rating allocations are as of 30 September 2010.UBS Investment Research: Global Equity Rating Definitions UBS 12-Month Rating Definition Buy FSR is > 6% above the MRA. Neutral FSR is between -6% and 6% of the MRA. Sell FSR is > 6% below the MRA. UBS Short-Term Rating Definition Buy: Stock price expected to rise within three months from the time the rating was assigned Buy because of a specific catalyst or event. Sell: Stock price expected to fall within three months from the time the rating was assigned Sell because of a specific catalyst or event. UBS 4
Canadian Banks: Q4/F10 Snapshot 6 December 2010KEY DEFINITIONS Forecast Stock Return (FSR) is defined as expected percentage price appreciation plus gross dividend yield over the next 12months. Market Return Assumption (MRA) is defined as the one-year local market interest rate plus 5% (a proxy for, and not aforecast of, the equity risk premium). Under Review (UR) Stocks may be flagged as UR by the analyst, indicating that the stocks price target and/or rating aresubject to possible change in the near term, usually in response to an event that may affect the investment case or valuation. Short-Term Ratings reflect the expected near-term (up to three months) performance of the stock and do not reflect anychange in the fundamental view or investment case.Equity Price Targets have an investment horizon of 12 months.EXCEPTIONS AND SPECIAL CASESUK and European Investment Fund ratings and definitions are: Buy: Positive on factors such as structure, management,performance record, discount; Neutral: Neutral on factors such as structure, management, performance record, discount; Sell:Negative on factors such as structure, management, performance record, discount.Core Banding Exceptions (CBE): Exceptions to the standard +/-6% bands may be granted by the Investment ReviewCommittee (IRC). Factors considered by the IRC include the stocks volatility and the credit spread of the respective companysdebt. As a result, stocks deemed to be very high or low risk may be subject to higher or lower bands as they relate to the rating.When such exceptions apply, they will be identified in the Company Disclosures table in the relevant research piece.Research analysts contributing to this report who are employed by any non-US affiliate of UBS Securities LLC are notregistered/qualified as research analysts with the NASD and NYSE and therefore are not subject to the restrictions contained inthe NASD and NYSE rules on communications with a subject company, public appearances, and trading securities held by aresearch analyst account. The name of each affiliate and analyst employed by that affiliate contributing to this report, if any,follows.UBS Securities Canada Inc: Peter A. Rozenberg.Company Disclosures Company Name Reuters 12-mo rating Short-term rating Price Price date 16 Bank of Montreal BMO.TO Neutral N/A C$59.89 03 Dec 2010 2, 3, 4a, 4b, 5a, 6, 16 Bank of Nova Scotia BNS.TO Buy N/A C$55.63 03 Dec 2010 Canadian Imperial Bank of 2, 4a, 4b, 5a, 5b, 6, 16 CM.TO Buy N/A C$78.50 03 Dec 2010 Commerce National Bank of Canada NA.TO Neutral N/A C$69.37 03 Dec 2010 2, 4a, 4b, 5a, 5b, 6, RBC Financial Group 16 RY.TO Buy N/A C$53.25 03 Dec 2010 2, 4a, 4b, 5b, TD Bank Financial Group 6, 16 TD.TO Neutral N/A C$72.23 03 Dec 2010Source: UBS. All prices as of local market close.Ratings in this table are the most current published ratings prior to this report. They may be more recent than the stock pricingdate2. UBS AG, its affiliates or subsidiaries has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.3. UBS Securities LLC is acting as advisor to Royal Bank of Scotland on its announced agreement to sell its corporate and commercial banking operations in Chile to The Bank of Nova Scotia4a. Within the past 12 months, UBS AG, its affiliates or subsidiaries has received compensation for investment banking services from this company/entity.4b. Within the past 12 months, UBS Securities Canada Inc or an affiliate has received compensation for investment banking services from this company/entity.5a. UBS AG, its affiliates or subsidiaries expect to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.5b. UBS Securities Canada Inc or an affiliate expect to receive or intend to seek compensation for investment banking services from this company/entity within the next three months. UBS 5
Canadian Banks: Q4/F10 Snapshot 6 December 20106. This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.16. UBS Securities LLC makes a market in the securities and/or ADRs of this company.Unless otherwise indicated, please refer to the Valuation and Risk sections within the body of this report.For a complete set of disclosure statements associated with the companies discussed in this report, including information onvaluation and risk, please contact UBS Securities LLC, 1285 Avenue of Americas, New York, NY 10019, USA, Attention:Publishing Administration. UBS 6